tiprankstipranks
Trending News
More News >
Gain Therapeutics, Inc. (GANX)
:GANX
US Market
Advertisement

Gain Therapeutics (GANX) Technical Analysis

Compare
377 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Gain Therapeutics, Inc.’s (GANX) Moving Averages Convergence Divergence (MACD) indicator is 0.27, suggesting Gain Therapeutics, Inc. is a Sell.
Gain Therapeutics, Inc.’s (GANX) 20-Day exponential moving average is 2.59, while Gain Therapeutics, Inc.’s (GANX) share price is $3.14, making it a Buy.
Gain Therapeutics, Inc.’s (GANX) 50-Day exponential moving average is 2.25, while Gain Therapeutics, Inc.’s (GANX) share price is $3.14, making it a Buy.

Gain Therapeutics (GANX) Pivot Points

Nov 29, 2025, 06:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.57
2.65
2.78
2.86
2.99
3.07
3.20
Fibonacci
2.65
2.73
2.78
2.86
2.94
2.99
3.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gain Therapeutics (GANX) Moving Averages

Nov 29, 2025, 06:12 PM
Period
Simple
Exponential
MA5
2.88Buy
2.93Buy
MA10
2.86Buy
2.81Buy
MA20
2.48Buy
2.59Buy
MA50
2.13Buy
2.25Buy
MA100
1.91Buy
2.06Buy
MA200
1.92Buy
2.01Buy
Gain Therapeutics, Inc.’s (GANX) 10-Day exponential moving average is 2.81, while Gain Therapeutics, Inc.’s (GANX) share price is $3.14, making it a Buy.
Gain Therapeutics, Inc.’s (GANX) 100-Day exponential moving average is 2.06, while Gain Therapeutics, Inc.’s (GANX) share price is $3.14, making it a Buy.
Gain Therapeutics, Inc.’s (GANX) stock price is $3.14 and Gain Therapeutics, Inc.’s (GANX) 50-day simple moving average is 2.13, creating a Buy signal.
Gain Therapeutics, Inc.’s (GANX) stock price is $3.14 and Gain Therapeutics, Inc.’s (GANX) 100-day simple moving average is 1.91, creating a Buy signal.
Gain Therapeutics, Inc.’s (GANX) stock price is $3.14 and Gain Therapeutics, Inc.’s (GANX) 200-day simple moving average is 1.92, creating a Buy signal.

Gain Therapeutics (GANX) Technical Indicators

Nov 29, 2025, 06:12 PM
Name
Value
Implied Action
RSI (14)
69.69
Neutral
STOCH (9,6)
65.90
Neutral
STOCHRSI (14)
85.28
Sell
MACD (12,26)
0.27
Sell
ADX (14)
39.55
Neutral
Williams %R
-16.46
Sell
CCI (14)
101.15
Sell
ATR (14)
0.26
-
Ultimate Oscillator
59.05
Neutral
ROC
65.26
Buy
Gain Therapeutics, Inc.’s (GANX) Relative Strength Index (RSI) is 69.69, creating a Neutral signal.
Gain Therapeutics, Inc.’s (GANX) Trend Strength Indicator (ADX) is 39.55, creating a Neutral signal.
Gain Therapeutics, Inc.’s (GANX) Commodity Channel Index (CCI) is 101.15, creating a Sell signal.
Gain Therapeutics, Inc.’s (GANX) Price Rate of Change (ROC) is 65.26, creating a Buy signal.

FAQ

Is GANX a Buy, Hold, or Sell?
Based on GANX’s technical indicators, GANX is a Buy.
    What is GANX’s RSI (14)?
    GANX’s RSI (14) is 69.69, which suggests GANX is a Neutral.
      What is GANX’s MACD?
      GANX’s MACD is 0.27, which suggests GANX is a Sell.
        What is GANX’s 5-day moving average?
        GANX’s 5-day moving average is 2.88, which suggests GANX is a Buy.
          What is GANX’s 20-day moving average?
          GANX 20-day moving average is 2.48, which suggests GANX is a Buy.
            What is GANX’s 50-day moving average?
            GANX’s 50-day moving average is 2.13, which suggests GANX is a Buy.
              What is GANX’s 200-day moving average?
              GANX’s 200-day moving average is 1.92, which suggests GANX is a Buy.
                What is GANX’s Williams % R (14)?
                GANX’s Williams % R (14) is -16.46, which suggests GANX is a Sell.
                  What is GANX’s CCI (14)?
                  GANX’s CCI (14) is 101.15, which suggests GANX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis